Evidence map›Paper›PMID 25924895›Full record

ArticleRetrovirology2015

Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.

Sandrina DaFonseca, Julia Niessl, Sylvia Pouvreau, Vanessa Sue Wacleche, Annie Gosselin, Aurélie Cleret-Buhot, Nicole Bernard, Cécile Tremblay, Mohammad-Ali Jenabian, Jean-Pierre Routy and 1 more

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. The many faces of parasite calreticulin.Frontiers in immunology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. CD16Blood advances · 2018
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Sandrina DaFonsecaFaculty of Medicine, Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, QC, Canada. sdafonseca7@gmail.com.
Julia NiesslFaculty of Medicine, Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, QC, Canada. julia.niessl@web.de.
Sylvia PouvreauFaculty of Medicine, Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, QC, Canada. sylvia.pouvreau@gmail.com.
Vanessa Sue WaclecheFaculty of Medicine, Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, QC, Canada. vanessa.sue.wacleche@umontreal.ca.
Annie GosselinCHUM-Research Centre, 900 rue Saint-Denis, Tour Viger R, room R09.416, Montreal, QC, H2X 0A9, Canada. annie.gosselin.chum@gmail.com.
Aurélie Cleret-BuhotFaculty of Medicine, Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, QC, Canada. cleret.aurelie@gmail.com.
Nicole BernardChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada. nicole.bernard@mcgill.ca.
Cécile TremblayFaculty of Medicine, Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, QC, Canada. c.tremblay@umontreal.ca.
Mohammad-Ali JenabianChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada. jenabian.mohammad-ali@uqam.ca.
Jean-Pierre RoutyChronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada. jean-pierre.routy@mcgill.ca.
Petronela AncutaFaculty of Medicine, Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, QC, Canada. petronela.ancuta@umontreal.ca.
Université de Montréal · CACentre Hospitalier de l’Université de Montréal · CAMcGill University Health Centre · CA

Funding

Canadian Institutes of Health Research 103230Canadian Institutes of Health Research MOP-114957Canadian Institutes of Health Research MOP-82849
6 · The paper itself

Abstract

backgroundDepletion of mucosal Th17 cells during HIV/SIV infections is a major cause for microbial translocation, chronic immune activation, and disease progression. Mechanisms contributing to Th17 deficit are not fully elucidated. Here we investigated alterations in the Th17 polarization potential of naive-like CD4(+) T-cells, depletion of Th17-commited subsets during HIV pathogenesis, and Th17 restoration in response to antiretroviral therapy (ART).

resultsPeripheral blood CD4(+) T-cells expressing a naive-like phenotype (CD45RA(+)CCR7(+)) from chronically HIV-infected subjects receiving ART (CI on ART; median CD4 counts 592 cells/μl; viral load: <50 HIV-RNA copies/ml; time since infection: 156 months) compared to uninfected controls (HIV-) were impaired in their survival and Th17 polarization potential in vitro. In HIV- controls, IL-17A-producing cells mainly originated from naive-like T-cells with a regulatory phenotype (nTregs: CD25(high)CD127(-)FoxP3(+)) and from CD25(+)CD127(+)FoxP3(-) cells (DP, double positive). Th17-polarized conventional naive CD4(+) T-cells (nT: CD25(-)CD127(+)FoxP3(-)) also produced IL17A, but at lower frequency compared to nTregs and DP. In CI on ART subjects, the frequency/counts of nTreg and DP were significantly diminished compared to HIV- controls, and this paucity was further associated with decreased proportions of memory T-cells producing IL-17A and expressing Th17 markers (CCR6(+)CD26(+)CD161(+), mTh17). nTregs and DP compared to nT cells harbored superior levels of integrated/non-integrated HIV-DNA in CI on ART subjects, suggesting that permissiveness to integrative/abortive infection contributes to impaired survival and Th17 polarization of lineage-committed cells. A cross-sectional study in CI on ART subjects revealed that nTregs, DP and mTh17 counts were negatively correlated with the time post-infection ART was initiated and positively correlated with nadir CD4 counts. Finally, a longitudinal analysis in a HIV primary infection cohort demonstrated a tendency for increased nTreg, DP, and mTh17 counts with ART initiation during the first year of infection.

conclusionsThese results support a model in which the paucity of phenotypically naive nTregs and DP cells, caused by integrative/abortive HIV infection and/or other mechanisms, contributes to Th17 deficiency in HIV-infected subjects. Early ART initiation, treatment intensification with integrase inhibitors, and/or other alternative interventions aimed at preserving/restoring the pool of cells prone to acquire Th17 functions may significantly improve mucosal immunity in HIV-infected subjects.

Indexed as

Cell DifferentiationAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveCD4-Positive T-LymphocytesChronic DiseaseCross-Sectional StudiesHIV-1HIV InfectionsHumansLongitudinal StudiesTh17 CellsT-Lymphocyte SubsetsAnti-Retroviral Agents

Identifiers

PMID25924895
PMCPMC4438463
OpenAlexW2029016685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.